Cargando…
Genomic Designs of rAAVs Contribute to Pathological Changes in the Livers and Spleens of Mice
Recombinant AAV (rAAV) gene therapy is being investigated as an effective therapy for several diseases including hemophilia B. Reports of liver tumor development in certain mouse models due to AAV treatment and genomic integration of the rAAV vector has raised concerns about the long-term safety and...
Autores principales: | Mulcrone, Patrick L., Zhang, Junping, Pride, P. Melanie, Lam, Anh K., Frabutt, Dylan A., Ball-Kell, Susan M., Xiao, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730939/ https://www.ncbi.nlm.nih.gov/pubmed/36507314 http://dx.doi.org/10.1155/2022/6807904 |
Ejemplares similares
-
Subgenomic particles in rAAV vectors result from DNA lesion/break and non-homologous end joining of vector genomes
por: Zhang, Junping, et al.
Publicado: (2022) -
Chemical modification of AAV9 capsid with N-ethyl maleimide alters vector tissue tropism
por: Mulcrone, Patrick L., et al.
Publicado: (2023) -
Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS
por: Lam, Anh K., et al.
Publicado: (2022) -
Effects of Thermally Induced Configuration Changes on rAAV Genome’s Enzymatic Accessibility
por: Xu, Yinxia, et al.
Publicado: (2020) -
Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013)